S3
extracted with CH 2 Cl 2 (x 3) and the combined organic extracts were dried (Na 2 SO 4 ), filtered and concentrated in vacuo.
General procedure B: Formation of oxime
To a solution of aldehyde (1 eq) in EtOH at 0 °C was added a solution of hydroxylamine.HCl (2 eq) in water. After completion of the reaction, the mixture was quenched by the addition of H 2 O. The organics were extracted with CH 2 Cl 2 (x 3), washed with brine, dried (NaSO 4 ) and concentrated in vacuo to afford the desired oxime.
General procedure C: in situ formation of nitrile oxide and subsequent cycloaddition (with alkyne partner or dimerisation)
To a solution of oxime (1 eq) in CH2Cl2 at -78 °C was slowly added t-BuOCl (1.05 eq) and the reaction monitored for oxime consumption by TLC (approximately 5 min). For isoxazole formation, a solution of Et3N (1.5 eq) and alkyne (2eq) in CH2Cl2 (1 mL) was then added. For furoxan formation, only Et3N (1.5 eq) was added. The mixture was then allowed warm to RT. After 16 h, the reaction mixture was quenched by addition of saturated aqueous NH4Cl and extracted with CH2Cl2 (x 3). The organics were washed with brine, dried (Na2SO4) and concentrated in vacuo.
Experimental Details
The synthesis of 6-8 have been described previously. 
t-BuOCl
A mixture of t-butanol (t-BuOH) (8.00 ml, 83.6 mmol) and glacial acetic acid (5.20 ml, 92.8 mmol) was added to a vigorously stirred solution of sodium hypochlorite (NaOCl) (112 ml, ~1.08 M solution, 120 mmol) at 0 °C. The reaction mixture was left to stir for 14 min in the dark, before separating the organic layer, washing with brine (20 ml) and drying over oven-dried calcium chloride (CaCl 2 ). After filtering over glass wool (cloudy yellow solution), the product was stored in the fridge in an amber bottle over oven-dried CaCl 2 .
No further purification and no characterisation were necessary.
Hz, H 10 ), 3. 37-3.32 (1H, m, H 6 138.6, 128.3, 127.6, 127.5, 78.0, 75.1, 72.9, 70.3, 36.1, 30.9, 29.7, 29.4, 23.0, 22 152.9, 139.0, 128.7, 128.1, 127.9, 73.3, 72.9, 70.7, 70.5, 35.3, 31.0, 30.1, 27.3, 22.6, 19. 172.8, 165.3, 138.6, 128.4, 127.7, 127.5, 98.9, 78.7, 78.4, 72.9, 72.8, 72.7, 70.4, 36.4, 36.2, 31.8, 31.2, 31.0, 30.2, 29.8, 29.4, 25.4, 23.4, 23.3, 22.7, 22.1, 14 
3,5-bis(2S,6S)-6-[4-(benzyloxy)butyl]tetrahydropyranyl)isoxazole 10
General procedure C was followed with t-BuOCl (14.6 #l, 134 #mol) added to a solution of oxime 3 (37.0 mg, 130 µmol) in CH2Cl2 (1 mL) followed by alkyne 7 (50.0 mg, 180 µmol) and Et3N (26.0 #l, 190 #mol) 
3-[(2S,6S)-6-[4-(benzyloxy)butyl]tetrahydropyranyl]-5-[(2R',6S')-6'-[4-(benzyloxy)butyl]tetrahydropyranyl]isoxazole 11
General procedure C was followed with t-BuOCl (14.6 #l, 134 #mol) added to a solution of oxime 3 (37.0 mg, 130 µmol) in CH2Cl2 (1 mL) followed by alkyne 8 (50.0 mg, 180 µmol) and Et3N (26.0 #l, 190 #mol) 9, 78.9, 77.2, 73.3, 73.2, 72.7, 70.7, 70.6, 68.7, 36.6, 35.4, 31.5, 31.4, 30.9, 30.2, 27.9, 27.7, 23.8, 22.6, 22.5, 19.7 General procedure C was followed with t-BuOCl (14.6 #l, 134 #mol) added to a solution of oxime 4 (37.0 mg, 130 µmol) in CH2Cl2 (1 mL) followed by alkyne 7 (50.0 mg, 180 µmol) and Et3N (26.0 #l, 190 #mol) General procedure C was followed with t-BuOCl (11.9 #l, 109 #mol) added to a solution of oxime 4 (30.0 mg, 100 #mol) in CH2Cl2 (1 mL) followed by alkyne 8 (45.6 mg, 170 #mol) and Et3N (21.1 #l, 154 #mol) in CH2Cl2 (1 mL). Purification by flash column chromatography (5% EtOAc/hexane) provided isoxazole 13 (11.5 mg, 20%) as a colourless oil. 
3,4-(bis(2S,6S)-6-[4-(benzyloxy)butyl]tetrahydropyranyl)furoxan 14
General procedure C was followed with t-BuOCl (13.0 #l, 119 #mol) added to a solution of oxime 3 (33.0 mg, 113 #mol) in CH2Cl2 (1 mL) followed by Et3N (24.0 #l, 167 #mol).
Purification by flash column chromatography (10% EtOAc/hexane) provided furoxan 14 (14.5 mg, 44%) as a colourless oil. 
3,4-(bis(2R,6S)-6-hexyltetrahydropyranyl)furoxan 16
General procedure C was followed with t-BuOCl (26.0 #l, 221 #mol) added to a solution of oxime 5 (45.0 mg, 211 #mol) in CH2Cl2 (2 mL) followed by Et3N (43.0 #l, 317 #mol).
Purification by flash column chromatography (5% Et 2 O/hexane) provided furoxan 16 (28.0 mg, 64%) as a colourless oil. S10 + H 2A' ), 1.98-1.89 (2H, m, H 3A + H 3A' ), 1.73-1.27 (28H, m, H 2B + H 2B' + H 3B + H 3B' + H 4 + H 4' + H 6-10 + H 6'-10' ), 0.87 (3H, t, J = 6.8 Hz, H 11' ), 0.86 (3H, t, J = 6.7 Hz, H 11 ); 13 C NMR (100 MHz, CDCl 3 ) " 157. 9, 114.6, 73.7, 72.9, 67.0, 64.8, 35.6, 33.5, 31.9 (2 x), 30.8, 29.5 (2 x), 29.3, 25.9, 25.7, 25.7, 25.0, 22.7 72.4, 65.9, 35.6, 31.9, 31.0, 29.3, 26.8, 25.7, 22.7, 19.2, 14 
